Aug
18
2026
Ongoing debates over high prescription drug costs from major pharmaceutical companies continue to draw political attention. Lawmakers and regulators have pushed measures aimed at lowering prices for consumers. The cartoon depicts the challenge of reining in those costs as a high-stakes contest. It takes the position that aggressive action is needed to bring relief despite industry resistance.
